I-6-Chloro-2-methyl-2H-indazol-5-amine CAS 1893125-36-4 Ucoceko >98.0% (LCMS) Ensitrelvir (S-217622) I-COVID-19 ePhakathi yoMfanekiso ofakiweyo

6-Chloro-2-methyl-2H-indazol-5-amine CAS 1893125-36-4 Ucoceko >98.0% (LCMS) Ensitrelvir (S-217622) Intermediate COVID-19

Inkcazelo emfutshane:

Igama: 6-Chloro-2-methyl-2H-indazol-5-amine

CAS: 1893125-36-4

Ubunyulu: >98.0% (LCMS)

Imbonakalo: I-Brown eKhanya ukuya kwi-Grey Solid Powder

Umbindi we-Ensitrelvir (S-217622), COVID-19

Umgangatho ophezulu, iMveliso yoRhwebo

E-Mail: alvin@ruifuchem.com

Thumela i-imeyile kuthi

Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

Inkcazo:

Ubonelelo ngezoRhwebo lwe-Ensitrelvir (S-217622) abaPhakathi:
S-Ethylisothiourea Hydrobromide CAS 1071-37-0
2,4,5-Trifluorobenzyl Bromide CAS 157911-56-3
I-Trimethyloxonium Tetrafluoroborate CAS 420-37-1
I-6-Chloro-2-methyl-2H-indazol-5-amine CAS 1893125-36-4
3-(Chloromethyl)-1-methyl-1H-1,2,4-triazole hydrochloride CAS 135206-76-7
1,3,5-Triazine-2,4 (1H,3H)-dione, 3-(1,1-dimethylethyl)-6-(ethylthio)- CAS 1360105-53-8

Iipropati zeMichiza:

Igama leMchiza	I-6-Chloro-2-methyl-2H-indazol-5-amine
Inombolo yeCAS	1893125-36-4
Inombolo yeCAT	RF-PI1506
Ubume beStokhwe	Ikhona evenkileni
Ifomula yeemolekyuli	C8H8ClN3
Ubunzima beMolekyuli	181.62
Uphawu	Ruifu Chemical

Iinkcukacha:

Into	Iinkcukacha
Imbonakalo	I-Brown eKhanyayo ukuya kuMvumbi oLuqilima
Ubunyulu / Indlela yokuHlalutya	>98.0% (LCMS)
I-1 H NMR Spectrum	Ukungqinelana Nolwakhiwo
I-LCMS	Ukungqinelana Nolwakhiwo
Ilahleko ekomisweni	≤1.00%
Ukungcola ngokupheleleyo	<2.00%
Umgangatho woVavanyo	Umgangatho woShishino
Ukusetyenziswa	Umbindi we-Ensitrelvir (S-217622), COVID-19

Ukupakishwa kunye noGcino:

Iphakheji: Ibhotile, 25kg / Drum, okanye ngokwemfuno umthengi.

Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma.

Izinto eziluncedo:

FAQ:

Isicelo:

I-6-Chloro-2-methyl-2H-indazol-5-amine (i-CAS: 1893125-36-4) iphakathi kwe-Ensitrelvir (S-217622).I-Ensitrelvir nguShionogi & Co. lichiza elisebenza kakhulu lokuthomalalisa iintsholongwane elisebenza kanye njengePfizer's Paxlovid.I-Oral Xocova (Ensitrelvir), enendlela yokusebenza efanayo nePfizer's Paxlovid (Nirmatrelvir+Ritonavir), yohluka ngokuba kufuneka ithathwe kube kanye ngosuku, ngelixa ukusebenza konyango kwe-ensitrelvir kungabonakali kungaphantsi kwePaxlovid.Njengesikhumbuzo, i-Nirmatrelvir isetyenziswa kabini yonke imihla, kunye ne-booster emelwe yi-Ritonavir.I-Ensitrelvir yaba yipilisi yokuqala yasekhaya yaseJapan ukunyanga i-COVID-19, eyesithathu ukuba yamkelwe ngokusemthethweni eJapan;ngoFebruwari 2022.